1-3 of 3
Catherine Payen
Close
Sort by
Journal Articles

Prognostic Factors Affecting Progression Free Survival For Multiple Myeloma Patients Receiving Lenalidomide Maintenance After Autologous Transplantation. Follow-Up Analysis Of The IFM 2005-02 Trial

Gerald Marit, MD, Valérie Lauwers-Cances, MD, Denis Caillot, MD, Thierry Facon, MD, Cyrille Hulin, MD, Philippe Moreau, MD, Claire Mathiot, MD, Murielle Roussel, MD, Catherine Payen, MD, Pascale Olivier, PharmD, Hervé Avet-Loiseau, MD, PhD, Michel Attal, MD
Journal: Blood
Blood (2013) 122 (21): 3312.
https://doi.org/10.1182/blood.V122.21.3312.3312
Published: 2013
Journal Articles

Lenalidomide Maintenance After Stem-Cell Transplantation For Multiple Myeloma: Follow-Up Analysis Of The IFM 2005-02 Trial

Michel Attal, MD, Valérie Lauwers-Cances, MD, Gérald Marit, MD, Denis Caillot, MD, Thierry Facon, MD, Cyrille Hulin, MD, Philippe Moreau, MD, Claire Mathiot, MD, Murielle Roussel, MD, Catherine Payen, MD, Pascale Olivier, PharmD, Hervé Avet-Loiseau, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 406.
https://doi.org/10.1182/blood.V122.21.406.406
Published: 2013
Journal Articles

Maintenance Treatment with Lenalidomide After Transplantation for MYELOMA: Final Analysis of the IFM 2005-02.

Michel Attal, MD, Valerie cances Lauwers, Gerald Marit, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Denis Caillot, Thierry Facon, MD, Cyrille Hulin, Philippe Moreau, MD, Claire Mathiot, Murielle Roussel, Catherine Payen, H. Avet-Loiseau, jean Luc Harousseau
Journal: Blood
Blood (2010) 116 (21): 310.
https://doi.org/10.1182/blood.V116.21.310.310
Published: 2010